JPMorgan Chase & Co. Has Lowered Expectations for Clorox (NYSE:CLX) Stock Price

Clorox (NYSE:CLX) had its price target reduced by research analysts at JPMorgan Chase & Co. from $95.00 to $92.00 in a report issued on Thursday,Benzinga reports. The firm presently has an “underweight” rating on the stock. JPMorgan Chase & Co.‘s price target would suggest a potential downside of 4.30% from the company’s previous close.

Several other equities research analysts have also recently weighed in on CLX. TD Cowen boosted their price objective on Clorox from $98.00 to $111.00 and gave the stock a “hold” rating in a research note on Tuesday, March 31st. Evercore reaffirmed an “underperform” rating and issued a $110.00 price objective on shares of Clorox in a research note on Friday, May 1st. Royal Bank Of Canada dropped their target price on Clorox from $132.00 to $127.00 and set a “sector perform” rating for the company in a report on Thursday, April 9th. UBS Group boosted their target price on Clorox from $96.00 to $100.00 and gave the company a “neutral” rating in a research report on Thursday. Finally, Morgan Stanley decreased their price target on Clorox from $110.00 to $97.00 and set an “equal weight” rating on the stock in a report on Friday, May 1st. One investment analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and five have given a Sell rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Reduce” and a consensus price target of $103.47.

Clorox Price Performance

Shares of Clorox stock opened at $96.13 on Thursday. The firm has a market cap of $11.62 billion, a PE ratio of 15.61, a PEG ratio of 0.47 and a beta of 0.54. Clorox has a 12 month low of $84.70 and a 12 month high of $132.03. The stock has a 50 day moving average of $94.59 and a 200 day moving average of $104.01. The company has a current ratio of 0.84, a quick ratio of 0.65 and a debt-to-equity ratio of 27.03.

Clorox (NYSE:CLX) last posted its earnings results on Thursday, April 30th. The company reported $1.64 EPS for the quarter, beating analysts’ consensus estimates of $1.55 by $0.09. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The firm had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.67 billion. During the same period in the prior year, the company earned $1.45 EPS. The company’s quarterly revenue was up .1% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. On average, research analysts expect that Clorox will post 5.52 EPS for the current fiscal year.

Insider Activity

In other news, Director Pierre R. Breber purchased 5,000 shares of the business’s stock in a transaction dated Tuesday, May 5th. The shares were purchased at an average price of $85.82 per share, for a total transaction of $429,100.00. Following the completion of the purchase, the director owned 18,000 shares in the company, valued at approximately $1,544,760. This represents a 38.46% increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this link. Insiders own 0.63% of the company’s stock.

Institutional Trading of Clorox

A number of hedge funds have recently added to or reduced their stakes in the business. Wilkins Investment Counsel Inc. raised its position in Clorox by 250.6% during the fourth quarter. Wilkins Investment Counsel Inc. now owns 55,064 shares of the company’s stock worth $5,552,000 after acquiring an additional 39,360 shares during the period. Morningstar Investment Management LLC grew its position in shares of Clorox by 131.8% in the fourth quarter. Morningstar Investment Management LLC now owns 62,454 shares of the company’s stock valued at $6,297,000 after purchasing an additional 35,506 shares during the period. National Pension Service grew its position in shares of Clorox by 68.9% in the fourth quarter. National Pension Service now owns 27,537 shares of the company’s stock valued at $2,777,000 after purchasing an additional 11,233 shares during the period. Swiss Life Asset Management Ltd increased its stake in shares of Clorox by 221.4% during the third quarter. Swiss Life Asset Management Ltd now owns 86,426 shares of the company’s stock worth $10,656,000 after purchasing an additional 59,533 shares in the last quarter. Finally, Birch Hill Investment Advisors LLC purchased a new stake in shares of Clorox during the fourth quarter worth about $22,103,000. 78.53% of the stock is owned by hedge funds and other institutional investors.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.